Under hyperinsulinemia conditions, downregulation of insulin receptor substrate 2 (IRS2) led to impairment of the PI3K/Akt signaling cascade in metabolic tissues such as muscle and liver53. The gene discussed is IRS2; the disease is hyperinsulinism.